Aerobiotix

About Aerobiotix

Aerobiotix, Inc. is a privately held medical device company, founded in 2013, that specializes in air quality management solutions for healthcare and other institutional settings. The company was established by Dr. David Kirschman, a former neurosurgeon and seasoned entrepreneur in the medical device sector with extensive experience and numerous patents to his name. Dr. Kirschman's background as a physician and inventor in the orthopedic and biologic fields directly informs the company's focus on reducing airborne pathogens in critical environments like operating rooms.

The firm develops, manufactures, and markets a suite of proprietary air decontamination devices. Aerobiotix operates in the healthcare market, serving hospitals, ambulatory surgery centers (ASCs), and long-term care facilities. Its business model involves selling these devices and likely includes recurring revenue from the sale of disposable components such as filtration cartridges. A significant milestone was achieved in 2021 when the company received FDA 510(k) clearance for its Aerocure-MD medical air purification system, validating its technology for medical use. That same year, Aerobiotix secured $25 million in a growth equity financing round led by Vivo Capital with participation from Asahi Kasei Ventures to accelerate growth.

The company's core products, such as the Illuvia® and Aerocure series, utilize a combination of HEPA filtration, ultraviolet (UV) light, and proprietary technologies to eliminate airborne bacteria, viruses, and spores with high efficiency. The Illuvia® Sense system, for instance, is an FDA-registered Class II medical device specifically designed for operating rooms to reduce the risk of surgical site infections by providing a non-turbulent flow of ultraclean air. These systems are engineered to run continuously and quietly in occupied spaces, removing contaminants and providing real-time air quality monitoring data. This dual-action approach of filtration and UV destruction is a key feature, with data showing it can remove over 99.9% of harmful airborne microorganisms.